NO20071524L - Fremgangsmate for enantioselektiv fremstilling av sulfoksid-derivater - Google Patents

Fremgangsmate for enantioselektiv fremstilling av sulfoksid-derivater

Info

Publication number
NO20071524L
NO20071524L NO20071524A NO20071524A NO20071524L NO 20071524 L NO20071524 L NO 20071524L NO 20071524 A NO20071524 A NO 20071524A NO 20071524 A NO20071524 A NO 20071524A NO 20071524 L NO20071524 L NO 20071524L
Authority
NO
Norway
Prior art keywords
preparation
sulfoxide derivatives
enantioselective
enantioselective preparation
sulfoxide
Prior art date
Application number
NO20071524A
Other languages
English (en)
Norwegian (no)
Inventor
Avraham Cohen
Suzy Charbit
Frederic Martinet
Francois Schutze
Patricia Gizecki
Original Assignee
Sidem Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidem Pharma Sa filed Critical Sidem Pharma Sa
Publication of NO20071524L publication Critical patent/NO20071524L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20071524A 2004-10-05 2007-03-23 Fremgangsmate for enantioselektiv fremstilling av sulfoksid-derivater NO20071524L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410483A FR2876101B1 (fr) 2004-10-05 2004-10-05 Procede de preparation enantioselective de derives de sulfoxydes
PCT/FR2005/002447 WO2006037894A1 (fr) 2004-10-05 2005-10-05 Procede de preparation enantioselective de derives de sulfoxydes.

Publications (1)

Publication Number Publication Date
NO20071524L true NO20071524L (no) 2007-04-27

Family

ID=34949706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071524A NO20071524L (no) 2004-10-05 2007-03-23 Fremgangsmate for enantioselektiv fremstilling av sulfoksid-derivater

Country Status (21)

Country Link
US (1) US7528251B2 (zh)
EP (1) EP1802620B1 (zh)
JP (1) JP5213444B2 (zh)
KR (1) KR101258744B1 (zh)
CN (1) CN101035787B (zh)
AT (1) ATE417848T1 (zh)
AU (1) AU2005291156B2 (zh)
BR (1) BRPI0516465A (zh)
CA (1) CA2580446C (zh)
DE (1) DE602005011840D1 (zh)
DK (1) DK1802620T3 (zh)
ES (1) ES2319804T3 (zh)
FR (1) FR2876101B1 (zh)
IL (1) IL181831A (zh)
MX (1) MX2007003953A (zh)
NO (1) NO20071524L (zh)
NZ (1) NZ553841A (zh)
PL (1) PL1802620T3 (zh)
RU (1) RU2380357C2 (zh)
WO (1) WO2006037894A1 (zh)
ZA (1) ZA200702273B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101012141B (zh) * 2007-02-02 2012-05-23 沈阳药科大学 手性亚砜类化合物的制备方法
FR2925899B1 (fr) * 2007-12-27 2012-12-21 Sidem Pharma Sa Procede de preparation enantioselective de sulfoxydes.
MX2012000583A (es) 2009-07-16 2012-02-13 Bayer Cropscience Ag Procedimiento para la preparacion de derivados de 3-triazolil-sulfoxido quirales.
RU2448954C1 (ru) * 2010-10-18 2012-04-27 Учреждение Российской академии наук Институт катализа им. Г.К. Борескова Сибирского отделения РАН Способ получения сульфоксидов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
CN1453278A (zh) * 2002-04-23 2003-11-05 中国人民解放军军事医学科学院放射医学研究所 一种拉唑类化合物及其制备方法与应用
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
KR20130066701A (ko) * 2003-02-24 2013-06-20 미쓰비시 타나베 파마 코퍼레이션 테나토프라졸의 거울상 이성질체 및 치료를 위한 그 용도

Also Published As

Publication number Publication date
IL181831A (en) 2011-04-28
JP5213444B2 (ja) 2013-06-19
RU2380357C2 (ru) 2010-01-27
US7528251B2 (en) 2009-05-05
ES2319804T3 (es) 2009-05-12
IL181831A0 (en) 2007-07-04
MX2007003953A (es) 2007-06-14
WO2006037894A1 (fr) 2006-04-13
CN101035787A (zh) 2007-09-12
NZ553841A (en) 2010-09-30
CA2580446C (fr) 2013-05-21
AU2005291156A1 (en) 2006-04-13
ATE417848T1 (de) 2009-01-15
DK1802620T3 (da) 2009-04-06
EP1802620A1 (fr) 2007-07-04
CA2580446A1 (fr) 2006-04-13
FR2876101B1 (fr) 2007-03-02
ZA200702273B (en) 2008-06-25
CN101035787B (zh) 2013-03-27
JP2008515860A (ja) 2008-05-15
BRPI0516465A (pt) 2008-09-09
US20070299261A1 (en) 2007-12-27
AU2005291156B2 (en) 2011-12-22
FR2876101A1 (fr) 2006-04-07
RU2007116816A (ru) 2008-11-20
DE602005011840D1 (de) 2009-01-29
EP1802620B1 (fr) 2008-12-17
PL1802620T3 (pl) 2009-07-31
KR20070102660A (ko) 2007-10-19
KR101258744B1 (ko) 2013-04-29

Similar Documents

Publication Publication Date Title
Alegaon et al. Novel imidazo [2, 1-b][1, 3, 4] thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents
Ravi et al. N-chlorosuccinimide-promoted regioselective sulfenylation of imidazoheterocycles at room temperature
PE20070002A1 (es) Compuestos derivados de heteroaril como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo i
NO20075626L (no) Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
WO2008005914A3 (en) Novel glucokinase activators and methods of using same
ATE427926T1 (de) Cycloalkylaminderivate
NO20071524L (no) Fremgangsmate for enantioselektiv fremstilling av sulfoksid-derivater
CA3014791A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m1
ECSP056016A (es) Nuevos derivados de 2-piridinacarboxamida
CN1237159A (zh) 对映导构纯的碱性芳基－环烷基－羟基羧酸酯,其制备方法及其在药品中的应用
Qi et al. Synthesis of functionalized chromeno [2, 3-b] pyrrol-4 (1 H)-ones by silver-catalyzed cascade reactions of chromones/thiochromones and isocyanoacetates
DE602005011879D1 (de) Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten
Kapoorr et al. Photocatalytic oxidative heterocyclization of semicarbazones: an efficient approach for the synthesis of 1, 3, 4-oxadiazoles
PE20061099A1 (es) Compuestos de piridil acido acetico como inhibidores de peptidasa
NO20070400L (no) Organiske forbindelser
NO20076658L (no) Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes
Lamers et al. Benzo [c] isothiazole 2‐Oxides: Three‐Dimensional Heterocycles with Cross‐Coupling and Functionalization Potential
EA201070021A1 (ru) Способ сульфоксидирования биологически активных соединений
HK1167402A1 (en) Phenoxymethyl heterocyclic compounds
Mao et al. Visible-Light-Mediated Tandem Difluoromethylation/Cyclization of Alkenyl Aldehydes toward CF2H-Substituted Chroman-4-one Derivatives
KR20160077216A (ko) 트리시클릭 피페리딘 화합물
BR112012012458A2 (pt) novas formas polimórficas de metil {4,6-diamino-2-[1-(2-fluorobenzil)-1h-pirazolo [3,4-b] piridin-3-il] pirimidin-5-il} carbamato
Large et al. Potent bicyclic inhibitors of malarial cGMP-dependent protein kinase: approaches to combining improvements in cell potency, selectivity and structural novelty
Moczulski et al. Visible-light synthesis of 4-substituted-chroman-2-ones and 2-substituted-chroman-4-ones via doubly decarboxylative Giese reaction
Zheng et al. Enantiodivergent synthesis of both enantiomers of marine alkaloids haliclorensin and isohaliclorensin, a constituent of halitulin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application